NCT04064034已完成不适用
Evaluation of the Diagnostic Potential a Lateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Quiescin Sulfhydryl Oxidase 1 (QSOX1) in the blood
研究概览
简要总结
Researchers have developed a new test to measure a protein QSOX1 that is found to be elevated in subjects with pancreas cancer. Researchers are looking to use this test to compare subjects with pancreas cancer and subjects without pancreas cancer to see if this test could be used to diagnosis pancreas cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 17 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adult patients with biopsy-proven adenocarcinoma prior to receiving any therapy such as surgery, radiation or chemotherapy.
- •Patients without pancreas cancer.
- •Adult patients with benign pancreas disorders such as pancreatitis with imaging within 12 months (CT, MRI, EUS) documenting no cancer.
- •Healthy adults with blood specimens in an existing biobank.
- •Patients with pancreatic cystic lesions.
- •Adult patients undergoing clinically indicated EUS-guided FNA biopsy of pancreatic cystic lesions.
排除标准
- •Prior treatment for pancreas cancer.
- •Unable or unwilling to give consent.
结局指标
主要结局
Quiescin Sulfhydryl Oxidase 1 (QSOX1) in the blood
时间窗: Baseline
Number of subjects with the presence and concentration of QSOX1 peptide found in the blood samples by the lateral flow assay (LFA) test
次要结局
未报告次要终点
研究者
Douglas O. Faigel
Principal Investigator
Mayo Clinic
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Research for new biomarker about diagnosis and evaluation of disease condition for inflammatory bowel disease (IBD).Inflammatory bowel diseaseJPRN-UMIN000017831Kyoto Prefectural University of Medicine400
已完成
不适用
Study for new biomarker development for diagnosis and evaluation of disease activity in juvenile rheumatic diseasejuvenile idiopathic arthritis, juvenile systemic erythematosus, juvenile dermatomyositis, juvenile Sjoegren syndrome, juvenile connective tissue disease, Henoch-Schonlein purpura, juvenile polyarteritis nodosa, juvenile aortitis syndrome, ulcerative colitis, Crohn's diseaseJPRN-UMIN000014119Aichi Medical University Hospital100
进行中（未招募）
不适用
Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting PrognosisPlaque RuptureAcute Coronary SyndromesNCT06763835Xuebo Liu301
尚未招募
不适用
Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myelomaC90Multiple myeloma and malignant plasma cell neoplasmsDRKS00010830niversitätsklinikum Freiburg160
终止
不适用
An In-vitro Standardization of B Cell Elispot AssaysTransplant SensitizationPanel Reactive AntibodySensitization to HLA AntigensNCT01334281Northwestern University19